DUBLIN–(BUSINESS WIRE)–August 6, 2021–
The report “Pediatric Vaccine Global Market Report 2021: COVID-19 Growth and Change to 2030” has been added to ResearchAndMarkets.com’s offering.
Pediatric Vaccine Global Market Report 2021: COVID-19 Growth and Change through 2030 provides the strategists, marketers, and senior management with the critical information they need to assess the global pediatric vaccine market.
Major players in the pediatric vaccine market include GlaxoSmithKline plc, Pfizer Inc., Sanofi SA, Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd. and Panacea Biotec Ltd.
The global pediatric vaccine market is expected to grow from $28.97 billion in 2020 to $32.44 billion in 2021 at a compound annual growth rate (CAGR) of 12%.
The growth is mainly due to the companies resuming operations and adjusting to the new normal, while recovering from the COVID-19 impact, which had previously led to restrictive containment measures related to social distancing, operating on distance and the closure of commercial activities resulting in operational challenges.
The market is expected to reach $49.9 billion by 2025 at a CAGR of 11.4%.
The pediatric vaccine market consists of the sale of pediatric vaccines and associated services used to provide infants and children with immunity to specific diseases. The pediatric vaccine is a preparation of killed microorganisms, live attenuated organisms or live fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or more diseases in children. Pediatric vaccines are used in childhood immunization schedules to boost a child’s immunity or prevent diseases such as diphtheria, tetanus, whooping cough, flu, hepatitis B, polio, and many other infectious and non-infectious diseases.
Vaccine refusal by parents for their children is a prevailing tradition in many countries. Among the reasons for withholding children from vaccination are lack of knowledge, religious and philosophical objections, exaggerated concerns about vaccine safety, and others. More than half (51%) of pediatric services in the United States have policies to fire families who refuse childhood vaccines, according to a nationwide survey.
Demand for new vaccines is steadily growing to provide better immunization against challenging infectious diseases (eg tuberculosis, HIV/AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant-recombinant antigen formulations.
To meet the increasing demand for new vaccines, there is an ongoing search for pediatric vaccine manufacturers and developers to innovate vaccine design and manufacturing technologies. In January 2020, for example, Hilleman Laboratories, a global research and development organization, announced their plans to develop a new vaccine against Group B Streptococcus, a leading cause of neonatal infections in women, in the areas of maternal health and children.
The rising prevalence of chronic diseases such as tuberculosis, diphtheria and pneumonia in the age group of 15 years and younger will contribute to the growth of the pediatric vaccine market. The risk of serious disease outcomes and complications of infectious diseases increases in children and adolescents with chronic conditions.
The increased prevalence of chronic diseases in children increases the demand for immunization against chronic diseases, fueling the growth of the pediatric vaccine market.
Main topics covered:
2. Market Characteristics for Pediatric Vaccines
3. Market Trends and Strategies for Pediatric Vaccines
4. Impact of COVID-19 on Pediatric Vaccines
5. Market Size and Growth for Pediatric Vaccines
5.1. Global Historic Pediatric Vaccine Market, 2015-2020, $Billion
5.1.1. Market drivers
5.1.2. Restrictions on the market
5.2. Global Forecasting Market for Pediatric Vaccines, 2020-2025F, 2030F, $Billion
5.2.1. Market drivers
5.2.2. Restrictions on the market
6. Market Segmentation for Pediatric Vaccines
6.1. Global Pediatric Vaccine Market, Segmentation by Vaccine Type, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
6.2. Global Pediatric Vaccine Market, Segmentation by Technology, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Alive Attenuated Inactivated ToxoidConjugateOther Technologies
6.3. Global Pediatric Vaccines Market Segmentation by Application, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7. Pediatric Vaccines Market Analysis by Regions and Country
7.1. Global Pediatric Vaccine Market Split by Regions, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, USD Billion
7.2. Global Pediatric Vaccine Market Breakdown by Country, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
GlaxoSmithKline plcPfizer Inc.Sanofi SAMerck & Co., Inc.Indian Immunologicals LimitedAstraZeneca plcCSL LimitedMitsubishi Tanabe Pharma CorporationSerum Institute of India Pvt. Ltd.Panacea Biotec Ltd.Zydus CadilaBIO-MEDSquibbNovartisAbbott LaboratriesEli Lillyand CompanyF. Hoffmann-La Roche Ltd.Novo Nordisk A/SVF CorporationSinovac Biotech Ltd.Bristol-MyersSun Pharmaceutical Industries LtdSellas and Takeda Pharmaceutical Company LimitedDaiichi Sankyo
For more information on this report, please visit https://www.researchandmarkets.com/r/35qy9e
Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20210806005324/en/
Laura Wood, senior press manager
For EST business hours, call 1-917-300-0470
For USA/CAN Toll Free Call 1-800-526-8630
For GMT office hours, call +353-1-416-8900
INDUSTRY KEY WORD: INFECTION DISEASES PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 08/06/2021 09:14 AM/DISC: 08/06/2021 09:14 AM